Mei Ri Jing Ji Xin Wen·2026-01-14 03:52Group 1 - The pharmaceutical sector is leading the market with significant gains, driven by multiple overseas innovative drug collaborations and catalysts [1] - Notable partnerships include Rongchang Biopharma's licensing agreement with AbbVie, which involves an upfront payment of $650 million and potential milestone payments of $4.95 billion, along with double-digit sales royalties [1] - WuXi AppTec has projected a revenue increase of 15.84% for 2025, with adjusted net profit expected to rise by 41.33%, exceeding market expectations [1] Group 2 - AI in healthcare is gaining momentum, with OpenAI integrating health dialogue features into ChatGPT, allowing users to share medical records and connect with various health applications [2] - Tempus AI reported a 111% year-over-year increase in diagnostic revenue, reaching $955 million, highlighting the rapid growth of AI in the medical field [2] - The pharmaceutical sector's global competitiveness is strengthening, with ongoing commercialization and profitability, particularly in innovative drug companies and CXO sectors [2]